Advertisement
Research Article| Volume 6, ISSUE 4, P148-151, October 1988

Direct T-cell effects of minoxidii

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Minoxidil has been shown to induce hair regrowth in alopecia areata1–4 by mechanisms that remain largely unknown. Alopecia areata is histologically characterized by miniaturized follicles with varying degrees of degeneration5 and by a dense perifollicular infiltration of T lymphocytes (helper, suppressor, and activated), Langerhans cells, and monocytes.6,7 T lymphocytes appear to be the predominant cell type in the perifollicular infiltrates and, by implication, may be of pathogenic significance in the hair loss process. Changes in perifollicular T-cell and activated T-cell populations have been found after treatment with minoxidil.7 Responders to topical 5% minoxidil treatment (ie, those patients who had terminal hair regrowth) have shown decreases in tissue T cells and simultaneous increases in peripheral blood T cells.7
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinics in Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Weiss VC
        • West DP
        • Fu TS
        • et al.
        Alopecia areata treated with topical minoxidil.
        Arch dermatol. 1984; 120: 457-463
        • Fiedler-Weiss VC
        • West DP
        • Buys CM
        • et al.
        Topical minoxidil dose-response effect in alopecia areata.
        Arch dermatol. 1986; 122: 180-182
        • Fiedler-Weiss VC
        Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata.
        J Am Acad dermatol. 1987; 16: 745-748
        • Fiedler-Weiss VC
        • Rumsfield J
        • Buys CM
        • et al.
        Evaluation of oral minoxidil in the treatment of alopecia areata.
        Arch dermatol. 1987; 123: 1488-1490
        • Fiedler-Weiss VC
        Potential mechanisms of minoxidilinduced hair growth in alopecia areata.
        J Am Acad dermatol. 1987; 16: 653-656
        • Perret CH
        • Brocker EB
        • Wiesner-Menzel L
        • et al.
        In situ demonstration of T-cells in alopecia areata.
        Arch dermatol. Res. 1982; 273: 155-158
        • Fiedler-Weiss VC
        • Buys CM
        Immunohistochemical characterization of the cellular infiltrate in severe alopecia areata before and after minoxidil treatment.
        dermatologica. 1987; 175: 29-35
        • Fiedler-Weiss VC
        • Buys CM
        Response to minoxidil in severe alopecia areata correlates with T-lymphocyte stimulation.
        Br J dermatol. 1987; 117: 759-763
        • Fiedler-Weiss VC
        • Buys CM
        Alopecia areata and control lymphocyte blastogenesis suppressed by in vitro minoxidil.
        J Invest dermatol. 1986; 87: 139
        • Boyum A
        Separation of leukocytes from blood and bone marrow.
        Scand J Clin Lab Invest. 1968; 21: 77-109
        • Fiedler-Weiss VC
        • Johnson GA
        • Buys CM
        • et al.
        Minoxidil sulfate and sulfotransferase activity in alopecia areata.
        Clinical Research. 1987; 35: 682A